Finless Foods: Lab-grown fish startup that uses genetic engineering nears commercialization

Finless Foods hosts a tasting of edible fish grown from cells in September 2017. Credit: Finless Foods

Finless Foods – one of a new wave of start-ups in the rapidly heating-up cultured fish arena – has raised $3.5m in a seed round that cofounder and CEO Mike Selden says will “bring us to the end of our initial R&D phase, meaning we’ll have the tools necessary to move into production pending the closing of a Series A.”

In a post on medium, Selden said the round – led by Silicon Valley-based VC rm Draper Associates – had been completed….

“The opportunity this money gives us to perfect our science and create delicious, safe, and healthy food is genuinely exciting to our entire team. We’ve already dramatically lowered cost and secured precious cellular material that will push us into rapid commercialization within years, not decades.”


As for the GMO factor, he said: “We’re not GMO [according to the ‘bioengineered’ definition enshrined in the federal GMO labeling legislation – not yet in force GMO]; we use genetic engineering in the creation of the growth factors used in our growth medium, but the proteins are not present in the final product.”

Read full, original article: Cultured fish co Finless Foods raises $3.5m, predicts “rapid commercialization within years, not decades”

Outbreak Daily Digest
Biotech Facts & Fallacies
GLP Podcasts
Infographic: Here’s where GM crops are grown around the world today

Infographic: Here’s where GM crops are grown around the world today

Do you know where biotech crops are grown in the world? This updated ISAAA infographics show where biotech crops were ...
News on human & agricultural genetics and biotechnology delivered to your inbox.
glp menu logo outlined

Newsletter Subscription

* indicates required
Email Lists
Send this to a friend